𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo

✍ Scribed by Philip Meuleman; Joseph Hesselgesser; Matthew Paulson; Thomas Vanwolleghem; Isabelle Desombere; Hans Reiser; Geert Leroux-Roels

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
290 KB
Volume
48
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis

The viral life cycle of the hepatitis C virus (HCV) has been studied mainly using different in vitro cell culture models. Studies using pseudoviral particles (HCVpp) and more recently cell culture-derived virus (HCVcc) suggest that at least three host cell molecules are important for HCV entry in vitro: the tetraspanin CD81, the scavenger receptor class B member I, and the tight junction protein Claudin-1. Whether these receptors are equally important for an in vivo infection remains to be demonstrated. We show that CD81 is indispensable for an authentic in vivo HCV infection. Prophylactic treatment with anti-CD81 antibodies completely protected human liver-uPA-SCID mice from a subsequent challenge with HCV consensus strains of different genotypes. Administration of anti-CD81 antibodies after viral challenge had no effect.

Conclusion:

Our experiments provide evidence for the critical role of cd81 in a genuine hcv infection in vivo and open new perspectives for the prevention of allograft reinfection after orthotopic liver transplantation in chronically infected hcv patients.

πŸ“œ SIMILAR VOLUMES

CD81 nucleotide mutation in hepatocellul
CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection
✍ Jun Itakura; Kazuyoshi Nagayama; Nobuyuki Enomoto; Naoya Sakamoto; Junichi Tazaw πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 526 KB

Mechanisms determining the chronicity or the pattern of clinical course of hepatitis C virus (HCV) infections have not been clarified. Recently, CD81 was reported to bind the E2 protein of HCV and was suggested to function as a cellular receptor for HCV. Accordingly, the hypothesis was examined that

Immunoglobulin M and A antibodies to hep
Immunoglobulin M and A antibodies to hepatitis C core antigen in chronic hepatitis C virus infection
✍ George K. K. Lau; Richard Lesniewski; Rhonda G. Johnson; Gary L. Davis; Johnson πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 367 KB πŸ‘ 1 views

## Abstract To determine the prevalence and clinical significance of IgM and IgA antibody to hepatitis C virus (HCV) core antigen in chronic HCV infection, sera from 47 patients were tested for immunoglobulin class M (IgM) and immunoglobulin A (IgA) antibody to HCV core antigen by solid‐phase enzym

Antibody convergence along a common idio
Antibody convergence along a common idiotypic axis in immunodeficiency virus and hepatitis C virus infections
✍ Michael D. Grant πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 154 KB

## Abstract The anti‐idiotypic antibody 1F7 selectively binds antibodies against human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) __gag, pol__, and __env__ proteins. We tested anti‐hepatitis C virus (HCV) antibodies to investigate selection of the 1F7 idiotype on antibodie

Hepatitis C virus infection in dialysis
Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response
✍ Negba Hanuka; Emanuel Sikuler; David Tovbin; Lewis Neville; Ofer Nussbaum; Marco πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 195 KB πŸ‘ 1 views

## Abstract Cryptic hepatitis C virus (HCV) infection relates to patients infected chronically with HCV that are seronegative but have HCV‐RNA. These patients are not identified by the standard serological tests for HCV, which are based on detection of antibodies to core, NS3 and NS5 antigens. They